查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1716361

2032 年經直腸超音波市場預測：按產品、技術、應用、最終用戶和地區分類的全球分析

Transrectal Ultrasound Market Forecasts to 2032 - Global Analysis By Product (Systems and Transducers), Technology (2D Ultrasound, 3D/4D Ultrasound, Doppler Ultrasound and Contrast-Enhanced Ultrasound (CEUS)), Application, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3個工作天內

價格

根據 Stratistics MRC 的數據，全球經直腸超音波市場預計在 2025 年達到 2.639 億美元，到 2032 年將達到 4.021 億美元，預測期內的複合年成長率為 6.2%。

經直腸超音波（TRUS）是一種主要用於檢查前列腺的醫學影像方式。將一個小型超音波探頭插入直腸並利用聲波創建詳細的圖像。 TRUS 有助於診斷前列腺疾病、進行切片檢查以及評估增大或腫瘤等異常情況。 TRUS 是一種安全、微創的方法，廣泛用於診斷前列腺癌等泌尿系統疾病。

根據美國癌症協會發布的數據，預計到2024年底，美國約有288,300名男性被診斷出罹患攝護腺癌。

攝護腺癌盛行率不斷上升

推動經直腸超音波(TRUS) 產業發展的主要因素之一是全球前列腺癌盛行率的不斷上升。 TRUS 對於診斷前列腺癌至關重要，因為它可以準確定位和早期發現病變。隨著即時彈性成像和 MRI-US 融合切片檢查等新成像技術使診斷更加準確，需求也在增加。隨著新興國家醫療保健基礎設施的改善和政府對前列腺癌研究的資助，市場也不斷擴大。綜合起來，這些因素使得 TRUS 成為對抗攝護腺癌發生率上升的重要工具。

替代影像方式的可用性

多參數磁振造影 (mpMRI) 等替代成像模式的可用性正在限制 TRUS 市場。多參數 MRI (mpMRI) 通常是首選方案，因為它可以提高前列腺病變的可見性並減少臨床上不重要的腫瘤的檢測。此外，mpMRI 與標靶切片檢查技術結合使用時，與傳統的 TRUS 引導切片檢查相比，已證明具有更高的診斷準確性。由於這些尖端成像技術的使用日益增多，TRUS 的潛在擴展受到限制，尤其是在醫療保健系統已經成熟的地區。

與標靶切片檢查技術的整合

將 TRUS 與 MRI-US 融合切片檢查等標靶切片檢查技術相結合，可提供巨大的成長機會。透過促進即時成像和對令人擔憂的病變的精確定位，這種組合提高了前列腺癌檢測的準確性。此外，微超音波技術的改進將實現更高解析度的成像，進一步改善診斷結果。這些發展正在推動從傳統診斷技術向更複雜技術的轉變，開啟新的市場可能性。

成本和報銷問題

先進的 TRUS 系統的高成本和嚴格的報銷指南威脅著市場擴張。此類設備的成本仍然是許多地區（尤其是較貧窮的國家）醫護人員面臨的問題。此外，嚴格的監管要求和因安全問題而導致的產品召回可能會阻礙市場擴張。

COVID-19的影響：

COVID-19 疫情導致醫療服務中斷，對經直腸超音波市場產生了負面影響。由於嚴格的社交隔離措施和醫院就診次數的減少，前列腺癌的診斷程序減少。疫情導致的需求下降也是由於人們擔心超音波技術可能會傳播感染。但隨著醫療機構的恢復和安全措施的改善，預計該行業將在疫情後恢復勢頭並呈現穩步發展。

預計預測期內醫院部門將實現最大幅度成長。

由於醫院基礎設施完善且擁有大量合格人員，預計在預測期內醫院部門將佔據最大的市場佔有率。隨著前列腺相關疾病的盛行率不斷上升，患者選擇在醫院進行診斷和治療。此外，醫院經常可以使用尖端成像技術，包括 MRI 融合功能和具有即時彈性成像的高解析度 TRUS 系統。公立醫院和私立醫院都能滿足不同病患的需求，確保其在這一細分市場中的主導地位。

預計預測期內 3D/4D超音波領域將以最高的複合年成長率成長。

預計 3D/4D超音波領域將在預測期內見證最高的成長率。這是由於成像能力的提高，可以精確觀察前列腺結構。這些最先進的儀器提供品質和準確度更高的即時影像，有助於更好地診斷。與重點切片檢查技術相結合，臨床結果進一步改善。先進的影像技術和對前列腺癌診斷新方法日益成長的需求是這一市場爆炸式成長的主要驅動力。

比最大的地區

在預測期內，北美預計將佔據最大的市場佔有率，因為它擁有完善的醫療保健系統和較高的前列腺癌發病率。該地區已撥出大量資金用於研究和開發舉措，以加強診斷技術。強勁的市場需求也是有吸引力的報銷規定和對早期檢測的高度認知的結果。產業巨頭確保醫院和診斷機構能夠使用尖端的 TRUS 系統，這也推動了該地區的成長。

複合年成長率最高的地區：

預計亞太地區在預測期內的複合年成長率最高。這是由於中國等國家對前列腺疾病早期診斷的認知不斷提高以及醫療保健支出不斷增加。隨著與老齡化相關的前列腺疾病變得越來越普遍，該地區老年人口將會增加，從而增加對 TRUS 設備的需求。此外，鼓勵採用醫療技術和改善醫療保健基礎設施的政府計劃正在幫助推動整個亞太地區的市場擴張。

免費客製化服務：

訂閱此報告的客戶可享有以下免費自訂選項之一：

  • 公司簡介
    • 對其他市場公司（最多 3 家公司）進行全面分析
    • 主要企業的SWOT分析（最多3家公司）
  • 地理細分
    • 根據客戶興趣對主要國家市場進行估計、預測和複合年成長率（註：基於可行性檢查）
  • 競爭基準化分析
    • 根據產品系列、地理分佈和策略聯盟對主要企業基準化分析

目錄

第1章執行摘要

第2章 前言

  • 概述
  • 相關利益者
  • 研究範圍
  • 調查方法
    • 資料探勘
    • 數據分析
    • 數據檢驗
    • 研究途徑
  • 研究材料
    • 初級研究資訊來源
    • 次級研究資訊來源
    • 先決條件

第3章市場走勢分析

  • 驅動程式
  • 限制因素
  • 機會
  • 威脅
  • 產品分析
  • 技術分析
  • 應用分析
  • 最終用戶分析
  • 新興市場
  • COVID-19的影響

第4章 波特五力分析

  • 供應商的議價能力
  • 買家的議價能力
  • 替代品的威脅
  • 新進入者的威脅
  • 競爭對手之間的競爭

5. 全球經直腸超音波市場（按產品）

  • 系統
    • 基於購物車的系統
    • 可攜式/手持式系統
  • 感應器

6. 全球經直腸超音波市場（按技術）

  • 2D超音波
  • 3D/4D超音波
  • 多普勒超音波
  • 造影超音波（CEUS）

7. 全球經直腸超音波市場（依應用）

  • 攝護腺癌
  • 良性攝護腺增生（BPH）
  • 男性不孕症診斷
  • 其他用途

8. 全球經直腸超音波市場（依最終用戶）

  • 醫院
  • 診斷影像中心
  • 泌尿系統診所
  • 門診手術中心（ASC）
  • 學術和研究機構

9. 全球經直腸超音波市場（按地區）

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 義大利
    • 法國
    • 西班牙
    • 其他歐洲國家
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 紐西蘭
    • 韓國
    • 其他亞太地區
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地區
  • 中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 卡達
    • 南非
    • 其他中東和非洲地區

第10章 重大進展

  • 協議、夥伴關係、合作和合資企業
  • 收購與合併
  • 新產品發布
  • 業務擴展
  • 其他關鍵策略

第11章 公司概況

  • Echo-Son SA
  • Esaote SpA
  • Exact Imaging
  • Fujifilm Holdings Corporation
  • GE Healthcare
  • KOELIS
  • Koninklijke Philips NV
  • Siemens Healthineers AG
  • Sonablate Corp
  • The Prometheus Group
  • EDAP TMS SA
  • Strata Imaging
  • HALO Medical Technologies
  • Telemed Medical Systems
  • BK Medical
  • Bracco Imaging SpA
Product Code: SMRC29172

According to Stratistics MRC, the Global Transrectal Ultrasound Market is accounted for $263.9 million in 2025 and is expected to reach $402.1 million by 2032, growing at a CAGR of 6.2% during the forecast period. Transrectal ultrasound (TRUS), a medical imaging method, primarily examines the prostate gland. A tiny ultrasound probe is inserted into the rectum to create detailed images using sound waves. TRUS helps diagnose prostate disorders, direct biopsies, and assess anomalies like enlargement or tumors. It is a widely used, safe, and minimally invasive method for identifying urological conditions, including prostate cancer.

According to data published by the American Cancer Society, approximately 288,300 men in the U.S. were estimated to be diagnosed with prostate cancer by the end of 2024

Market Dynamics:

Driver:

Increasing prevalence of prostate cancer

One major factor propelling the transrectal ultrasound (TRUS) industry is the increasing incidence of prostate cancer worldwide. Because TRUS allows for precise lesion localization and early identification, it is essential in the diagnosis of prostate cancer. Demand has also gone up because new imaging technologies, like real-time elastography and MRI-US fusion biopsies, have made diagnosis more accurate. The market is also growing as a result of enhanced healthcare infrastructure in emerging nations and government financing for prostate cancer research. When taken as a whole, these elements make TRUS a vital instrument for combating the rising incidence of prostate cancer.

Restraint:

Availability of alternative imaging techniques

The availability of substitute imaging modalities, such as multiparametric MRI (mpMRI), constrains the TRUS market. Multiparametric MRI (mpMRI) is often the preferred option due to its enhanced visibility of prostate lesions and its ability to reduce the detection of tumors that are not clinically significant. Also, when used with targeted biopsy methods, mpMRI has been found to be more accurate in diagnosing compared to regular TRUS-guided biopsies. TRUS's potential for expansion is constrained by the growing use of these cutting-edge imaging techniques, particularly in areas with established healthcare systems.

Opportunity:

Integration with targeted biopsy techniques

Combining TRUS with targeted biopsy methods like MRI-US fusion biopsies presents a significant opportunity for growth. By facilitating real-time imaging and accurate targeting of worrisome lesions, this combination improves the detection accuracy of prostate cancer. Furthermore, improvements in micro-ultrasound technology provide imaging with higher resolution, which enhances diagnostic results even more. These developments are propelling a change from traditional diagnostic techniques to more sophisticated ones, opening up new market potential prospects.

Threat:

Cost and reimbursement issues

The high expenses of sophisticated TRUS systems and restrictive reimbursement guidelines threaten the market's expansion. The cost of these gadgets continues to be a problem for healthcare practitioners in many areas, especially in poor nations. Furthermore, strict regulatory requirements and product recalls triggered by safety concerns may hinder market expansion.

Covid-19 Impact:

The COVID-19 epidemic negatively impacted the transrectal ultrasound market by causing disruptions in healthcare services. Prostate cancer diagnostic procedures decreased as a result of strict social distancing measures and fewer hospital visits. The pandemic's drop in demand was also due to worries about ultrasound technology spreading infections. Nonetheless, the industry is anticipated to regain momentum and show steady development in the post-pandemic phase as healthcare institutions recover and implement improved safety measures.

The hospitals segment is expected to be the largest during the forecast period

The hospitals segment is expected to account for the largest market share during the forecast period because of their sophisticated infrastructure and abundance of qualified personnel. Patients choose hospital-based diagnoses and treatments due to the rising incidence of prostate-related illnesses. Additionally, hospitals frequently have access to state-of-the-art imaging technologies such as MRI fusion capabilities or high-resolution TRUS systems with real-time elastography. Both public and private hospitals, catering to various patient demands, guarantee their dominant position in this market segment.

The 3D/4D ultrasound segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the 3D/4D ultrasound segment is predicted to witness the highest growth rate. This is due to its enhanced imaging capabilities, which enable accurate observation of prostate architecture. These cutting-edge devices provide real-time images with improved quality and accuracy, facilitating better diagnosis. Their combination with focused biopsy procedures further enhances clinical results. The development of imaging technology and the increasing need for novel approaches to prostate cancer diagnostics are the main drivers of this market's explosive expansion.

Region with largest share:

During the forecast period, the North America region is expected to hold the largest market share because of its established healthcare system and high incidence of prostate cancer. Considerable funds are allocated to research and development initiatives to enhance diagnostic technologies in the region. Strong market demand is also a result of attractive reimbursement regulations and high awareness of early-stage disease identification. Major industry companies guarantee access to cutting-edge TRUS systems in hospitals and diagnostic facilities, which is fueling the growth in the region.

Region with highest CAGR:

Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR. This is due to the increasing awareness of early prostate disease diagnosis and the rising healthcare costs in countries such as China and India. As age-related prostate disorders become more common, the region's growing geriatric population base increases demand for TRUS equipment. Furthermore, government programs encouraging the adoption of medical technology and improvements to healthcare infrastructure are driving market expansion throughout Asia Pacific.

Key players in the market

Some of the key players in Transrectal Ultrasound Market include Echo-Son SA, Esaote SpA, Exact Imaging, Fujifilm Holdings Corporation, GE Healthcare, KOELIS, Koninklijke Philips N.V., Siemens Healthineers AG, Sonablate Corp, The Prometheus Group, EDAP TMS SA, Strata Imaging, HALO Medical Technologies, Telemed Medical Systems, BK Medical, and Bracco Imaging S.p.A.

Key Developments:

In November 2024, EDAP TMS SA announced positive clinical results regarding its robotic High-Intensity Focused Ultrasound (HIFU) treatment for deep infiltrating endometriosis at the 2024 AAGL Global Congress. A study presented by Professor Gil Dubernard compared the outcomes of HIFU therapy to traditional surgical methods, revealing that patients undergoing HIFU experienced significantly reduced moderate and severe postoperative complications, shorter hospital stays, and improved overall health. The study analyzed data from 120 patients and found that HIFU could serve as a less invasive alternative to surgery, addressing a condition with limited treatment options. The company is working on further evaluations and plans to discuss these findings with the FDA as it advances its Phase 3 trial for HIFU treatment.

In September 2024, Koelis, SAS, a global leader and innovator in prostate care, announced the release of a new, compact 3D transducer for transperineal fusion biopsy and treatment. Koelis is now compatible with both the market leading high-level disinfection systems (Trophon(R) and Astra(R)VR).

In March 2024, GE HealthCare (Nasdaq: GEHC) announced the launch of Prostate Volume Assist (PVA) urology-based artificial intelligence (AI) software feature. As a global leader in ultrasound-guided solutions in urology, this AI-based software feature is designed to support clinicians in prostate imaging, biopsies and guiding treatment. This new feature assists urologists by offering a solution that improves workflow and quickly captures prostate volume. The added functionality with PVA can determine calculations and measurements of the organ with an automated, one-click process.

Product Covered:

  • Systems
  • Transducers

Technologies Covered:

  • 2D Ultrasound
  • 3D/4D Ultrasound
  • Doppler Ultrasound
  • Contrast-Enhanced Ultrasound (CEUS)

Applications Covered:

  • Prostate Cancer
  • Benign Prostatic Hyperplasia (BPH)
  • Male Infertility Diagnosis
  • Other Applications

End Users Covered:

  • Hospitals
  • Diagnostic Imaging Centers
  • Urology Clinics
  • Ambulatory Surgical Centers (ASCs)
  • Academic & Research Institutes

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2024, 2025, 2026, 2028, and 2032
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Product Analysis
  • 3.7 Technology Analysis
  • 3.8 Application Analysis
  • 3.9 End User Analysis
  • 3.10 Emerging Markets
  • 3.11 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Transrectal Ultrasound Market, By Product

  • 5.1 Introduction
  • 5.2 Systems
    • 5.2.1 Cart-Based Systems
    • 5.2.2 Portable/Handheld Systems
  • 5.3 Transducers

6 Global Transrectal Ultrasound Market, By Technology

  • 6.1 Introduction
  • 6.2 2D Ultrasound
  • 6.3 3D/4D Ultrasound
  • 6.4 Doppler Ultrasound
  • 6.5 Contrast-Enhanced Ultrasound (CEUS)

7 Global Transrectal Ultrasound Market, By Application

  • 7.1 Introduction
  • 7.2 Prostate Cancer
  • 7.3 Benign Prostatic Hyperplasia (BPH)
  • 7.4 Male Infertility Diagnosis
  • 7.5 Other Applications

8 Global Transrectal Ultrasound Market, By End User

  • 8.1 Introduction
  • 8.2 Hospitals
  • 8.3 Diagnostic Imaging Centers
  • 8.4 Urology Clinics
  • 8.5 Ambulatory Surgical Centers (ASCs)
  • 8.6 Academic & Research Institutes

9 Global Transrectal Ultrasound Market, By Geography

  • 9.1 Introduction
  • 9.2 North America
    • 9.2.1 US
    • 9.2.2 Canada
    • 9.2.3 Mexico
  • 9.3 Europe
    • 9.3.1 Germany
    • 9.3.2 UK
    • 9.3.3 Italy
    • 9.3.4 France
    • 9.3.5 Spain
    • 9.3.6 Rest of Europe
  • 9.4 Asia Pacific
    • 9.4.1 Japan
    • 9.4.2 China
    • 9.4.3 India
    • 9.4.4 Australia
    • 9.4.5 New Zealand
    • 9.4.6 South Korea
    • 9.4.7 Rest of Asia Pacific
  • 9.5 South America
    • 9.5.1 Argentina
    • 9.5.2 Brazil
    • 9.5.3 Chile
    • 9.5.4 Rest of South America
  • 9.6 Middle East & Africa
    • 9.6.1 Saudi Arabia
    • 9.6.2 UAE
    • 9.6.3 Qatar
    • 9.6.4 South Africa
    • 9.6.5 Rest of Middle East & Africa

10 Key Developments

  • 10.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 10.2 Acquisitions & Mergers
  • 10.3 New Product Launch
  • 10.4 Expansions
  • 10.5 Other Key Strategies

11 Company Profiling

  • 11.1 Echo-Son SA
  • 11.2 Esaote SpA
  • 11.3 Exact Imaging
  • 11.4 Fujifilm Holdings Corporation
  • 11.5 GE Healthcare
  • 11.6 KOELIS
  • 11.7 Koninklijke Philips N.V.
  • 11.8 Siemens Healthineers AG
  • 11.9 Sonablate Corp
  • 11.10 The Prometheus Group
  • 11.11 EDAP TMS SA
  • 11.12 Strata Imaging
  • 11.13 HALO Medical Technologies
  • 11.14 Telemed Medical Systems
  • 11.15 BK Medical
  • 11.16 Bracco Imaging S.p.A.

List of Tables

  • Table 1 Global Transrectal Ultrasound Market Outlook, By Region (2024-2032) ($MN)
  • Table 2 Global Transrectal Ultrasound Market Outlook, By Product (2024-2032) ($MN)
  • Table 3 Global Transrectal Ultrasound Market Outlook, By Systems (2024-2032) ($MN)
  • Table 4 Global Transrectal Ultrasound Market Outlook, By Cart-Based Systems (2024-2032) ($MN)
  • Table 5 Global Transrectal Ultrasound Market Outlook, By Portable/Handheld Systems (2024-2032) ($MN)
  • Table 6 Global Transrectal Ultrasound Market Outlook, By Transducers (2024-2032) ($MN)
  • Table 7 Global Transrectal Ultrasound Market Outlook, By Technology (2024-2032) ($MN)
  • Table 8 Global Transrectal Ultrasound Market Outlook, By 2D Ultrasound (2024-2032) ($MN)
  • Table 9 Global Transrectal Ultrasound Market Outlook, By 3D/4D Ultrasound (2024-2032) ($MN)
  • Table 10 Global Transrectal Ultrasound Market Outlook, By Doppler Ultrasound (2024-2032) ($MN)
  • Table 11 Global Transrectal Ultrasound Market Outlook, By Contrast-Enhanced Ultrasound (CEUS) (2024-2032) ($MN)
  • Table 12 Global Transrectal Ultrasound Market Outlook, By Application (2024-2032) ($MN)
  • Table 13 Global Transrectal Ultrasound Market Outlook, By Prostate Cancer (2024-2032) ($MN)
  • Table 14 Global Transrectal Ultrasound Market Outlook, By Benign Prostatic Hyperplasia (BPH) (2024-2032) ($MN)
  • Table 15 Global Transrectal Ultrasound Market Outlook, By Male Infertility Diagnosis (2024-2032) ($MN)
  • Table 16 Global Transrectal Ultrasound Market Outlook, By Other Applications (2024-2032) ($MN)
  • Table 17 Global Transrectal Ultrasound Market Outlook, By End User (2024-2032) ($MN)
  • Table 18 Global Transrectal Ultrasound Market Outlook, By Hospitals (2024-2032) ($MN)
  • Table 19 Global Transrectal Ultrasound Market Outlook, By Diagnostic Imaging Centers (2024-2032) ($MN)
  • Table 20 Global Transrectal Ultrasound Market Outlook, By Urology Clinics (2024-2032) ($MN)
  • Table 21 Global Transrectal Ultrasound Market Outlook, By Ambulatory Surgical Centers (ASCs) (2024-2032) ($MN)
  • Table 22 Global Transrectal Ultrasound Market Outlook, By Academic & Research Institutes (2024-2032) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.